13F-HR filed by Blue Owl Capital Holdings LP
Blue Owl Capital Holdings LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-15, with 43 holding rows worth $418,337,792.
- Accession
- 0000950123-24-002647
- Filer
- CIK 1858703
- Filed
- 2024-02-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 46 entries on the cover page, a total value of $418,337,792 stated on the cover page (in dollars after the unit check, H1), rows summing to $418,337,792 with VALUE read as dollars as filed, 13F file number 028-21866. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBlue Owl Credit Advisors LLC
- included managerBlue Owl GPSC Advisors LLC
- included managerBlue Owl Technology Credit Advisors LLC
- included managerBlue Owl GPSC IV Advisors LLC
- included managerBlue Owl Credit Private Fund Advisors LLC
- included managerBlue Owl Healthcare Opportunities Advisors
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PLIANT THERAPEUTICS INC | 729139105 | COM | 3,004,199 | $54,406,044 | dollars as filed | |
| ROBINHOOD MKTS INC | 770700102 | COM | 4,237,409 | $53,984,591 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 3,419,842 | $34,848,190 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 1,332,302 | $32,394,496 | dollars as filed | |
| KLAVIYO INC COM SER A | 49845K101 | Stock | 1,198,270 | $31,457,104 | dollars as filed | |
| BLUE OWL CAPITAL CORPORATION COM | 69121K104 | CEF | 2,045,070 | $30,185,233 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 3,122,499 | $22,794,243 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 2,292,990 | $17,105,705 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 3,414,468 | $15,535,829 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 352,633 | $14,020,688 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 263,238 | $12,588,041 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 1,234,760 | $11,396,835 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 1,493,252 | $8,462,577 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 140,260 | $8,101,418 | dollars as filed | |
| E2OPEN PARENT HOLDINGS INC | 29788T103 | COM CL A | 1,650,943 | $7,247,640 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 71,888 | $6,630,949 | dollars as filed | |
| TOASTINCCLASSCLASSA | 888787108 | STOK | 5,890,274 | $6,041,886 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 1,270,027 | $5,410,315 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 568,379 | $4,888,059 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 2,829,712 | $4,414,351 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 65,000 | $3,925,350 | dollars as filed | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 1,953,616 | $3,848,624 | dollars as filed | |
| DIREXION SHS ETF TR | 25460G716 | DAILY S&P BIOTEC | 340,000 | $3,294,600 | dollars as filed | |
| OMEGA THERAPEUTICS INC | 68217N105 | COMMON STOCK | 1,055,882 | $3,178,205 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 864,822 | $2,784,727 | dollars as filed | |
| DELL TECHNOLOGIES INC CL C | 24703L202 | Stock | 35,091 | $2,684,462 | dollars as filed | |
| ORCHARD THERAPEUTICS PLC | 68570P200 | ADR | 1,599,660 | $2,631,441 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 60,000 | $2,527,800 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 695,000 | $1,952,950 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 355,377 | $1,926,143 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 733,568 | $1,217,723 | dollars as filed | |
| GOHEALTH INC | 38046W204 | CL A NEW | 83,264 | $1,110,761 | dollars as filed | |
| BRAZE INC | 10576N102 | COM CL A | 17,726 | $941,782 | dollars as filed | |
| BLEND LABS INC | 09352U108 | CL A | 361,587 | $922,052 | dollars as filed | |
| RALLYBIO CORP | 75120L100 | COM | 350,240 | $837,074 | dollars as filed | |
| DESKTOP METAL INC | 25058X105 | COM CL A | 750,000 | $563,250 | dollars as filed | |
| FREELINE THERAPEUTICS HLDGS | 35655L206 | ADR | 86,654 | $551,986 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M113 | W EXP 10/31/2028 | 475,077 | $403,815 | dollars as filed | |
| Uber Technologies | 90353T100 | COM | 6,187 | $380,934 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 10,013 | $295,584 | dollars as filed | |
| FATHOM DIGITAL MFG CORP | 31189Y103 | COM | 50,000 | $222,915 | dollars as filed | |
| PRECISION BIOSCIENCES INC | 74019P108 | COM | 606,629 | $221,420 | dollars as filed | |
| Plum Acquisition Corp. III | G63290103 | Warrant | 666,666 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-24-002647 | this filing | 2024-02-15 | acceptance time not in the bulk data set |